Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Induction of PGF2α synthesis by cortisol through GR dependent induction of CBR1 in human amnion fibroblasts.

Endocrinology | 2014

Abundant evidence indicates a pivotal role of prostaglandin F2α (PGF2α) in human parturition. Both the fetal and maternal sides of the fetal membranes synthesize PGF2α. In addition to the synthesis of PGF2α from PGH2 by PGF synthase (PGFS), PGF2α can also be converted from PGE2 by carbonyl reductase 1 (CBR1). Here, we showed that there was concurrent increased production of cortisol and PGF2α in association with the elevation of CBR1 in human amnion obtained at term with labor versus term without labor. In cultured primary human amnion fibroblasts, cortisol (0.01-1μM) increased PGF2α production in a concentration-dependent manner, in parallel with elevation of CBR1 levels. Either siRNA-mediated knockdown of glucocorticoid receptor (GR) expression or GR antagonist RU486 attenuated the induction of CBR1 by cortisol. Chromatin immunoprecipitation (ChIP) showed an increased enrichment of both GR and RNA polymerase II to CBR1 promoter. Knockdown of CBR1 expression with siRNA or inhibition of CBR1 activity with rutin decreased both basal and cortisol-stimulated PGF2α production in human amnion fibroblasts. In conclusion, CBR1 may play a critical role in PGF2α synthesis in human amnion fibroblasts, and cortisol promotes the conversion of PGE2 into PGF2α via GR-mediated induction of CBR1 in human amnion fibroblasts. This stimulatory effect of cortisol on CBR1 expression may partly explain the concurrent increases of cortisol and PGF2α in human amnion tissue with labor, and these findings may account for the increased production of PGF2α in the fetal membranes prior to the onset of labor.

Pubmed ID: 24654784 RIS Download

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: R01 HD031514
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD 31514

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


AKR1C3 Antibody (Center) (antibody)

RRID:AB_10819466

This monoclonal targets AKR1C3 (Center)

View all literature mentions

AKR1B1 Antibody (C-term) (antibody)

RRID:AB_2224152

This polyclonal targets AKR1B1

View all literature mentions

Cox-2 (29) (antibody)

RRID:AB_627284

This monoclonal targets Cox-2 (29)

View all literature mentions

cPLA2 (4-4B-3C) (antibody)

RRID:AB_627288

This monoclonal targets cPLA2 (4-4B-3C)

View all literature mentions